Wichmann Dörte, Schempf Ulrike, Göpel Siri, Stüker Dietmar, Fusco Stefano, Königsrainer Alfred, Malek Nisar P, Werner Christoph R
Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
Department of Gastroenterology, Hepatology, Gastrointestinal Oncology, Geriatrics and Infectious diseases, University Hospital Tübingen, Tübingen, Germany.
Therap Adv Gastroenterol. 2022 Mar 23;15:17562848221086753. doi: 10.1177/17562848221086753. eCollection 2022.
Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a pandemic threat to global health. We are now in the fourth wave of this pandemic. As the pandemic developed, the requirements and therapeutic endoscopic procedures for SARS-CoV-2-positive patients underwent changes.
Analysis of implications for an endoscopy unit during the first and second/third waves of the COVID-19 pandemic with a focus on COVID-19-related process changing. Addressed are number of SARS-CoV-2-positive patients and endoscopic examinations performed in patients who tested positive for SARS-CoV-2 during the various waves, adherence to scheduled examinations, rotation of staff to COVID-dedicated structures and, finally, impact of vaccination on infection rate among endoscopic staff.
During the first wave, 10 SARS-CoV-2-positive in-house patients underwent a total of 22 gastrointestinal (GI) endoscopic procedures. During the second and third waves, 59 GI endoscopies were performed in 38 patients. While in the first wave, GI bleeding was the main indication for endoscopy (82%), in the second and third waves the main indication for endoscopy was endoscopic insertion of deep feeding tubes (78%; < 0.001). During the first wave, 5 (17%) of 29 Interdisciplinary Endoscopy Unit (IEU) staff members were moved to designated COVID wards, which was not necessary during the following waves. Lack of protective clothing was critical during the first wave, but not in the later waves. Screening tests for patients and staff were widely available after the first wave, and IEU staff was vaccinated during the second wave.
Strategies to ensure safe endoscopies with respect to preventing transmission of SARS-CoV-2 from patients to staff were effective. Organizational adjustments allowed the routine program to continue unaffected. Indications for GI endoscopies changed over time: during the first wave, GI endoscopies were performed for life-threatening indications, whereas later supportive procedures were the main indication.
自2019年12月以来,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对全球健康构成了大流行威胁。我们现在正处于这一大流行的第四波。随着大流行的发展,SARS-CoV-2阳性患者的需求和治疗性内镜检查程序发生了变化。
分析COVID-19大流行第一波和第二/三波期间对一个内镜科室的影响,重点关注与COVID-19相关的流程变化。涉及的内容包括各波期间SARS-CoV-2阳性患者的数量以及SARS-CoV-2检测呈阳性患者所进行的内镜检查、对预定检查的依从性、工作人员轮换至专门的COVID科室,最后是疫苗接种对内镜科室工作人员感染率的影响。
在第一波期间,10名SARS-CoV-2阳性住院患者共接受了22次胃肠道(GI)内镜检查。在第二波和第三波期间,38名患者接受了59次GI内镜检查。在第一波中,GI出血是内镜检查的主要指征(82%),而在第二波和第三波中,内镜检查的主要指征是内镜插入深饲管(78%;P<0.001)。在第一波期间,29名跨学科内镜科室(IEU)工作人员中有5人(17%)被调至指定的COVID病房,在随后的几波中则没有必要这样做。第一波期间防护服短缺至关重要,但在后续几波中并非如此。第一波之后患者和工作人员的筛查测试广泛可用,IEU工作人员在第二波期间接种了疫苗。
确保内镜检查安全以防止SARS-CoV-2从患者传播给工作人员的策略是有效的。组织调整使常规项目能够不受影响地继续进行。GI内镜检查的指征随时间而变化:在第一波期间,进行GI内镜检查是为了处理危及生命的指征,而后来支持性操作成为主要指征。